https://www.selleckchem.com/products/sirtinol.html
Combination drug therapy has become an effective strategy for inflammation control. The anti‑inflammatory capacities of silibinin and thymol have each been investigated on its own, but little is known about the synergistic anti-inflammatory effects of these two compounds. This study aims to investigate the synergistic anti-inflammatory effects of silibinin and thymol when administered in combination to lipopolysaccharide (LPS)-induced RAW264.7 cells. RAW264.7 cells were pre-treated with silibinin and thymol individually or in combinati
Like
Comment
Share
